Lindsay Androski

Lindsay Androski has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Arbutus Biopharma Corp and Eloxx Pharmaceuticals, Inc. Over a trading history stretching from 16 October 2024 to 1 October 2026, the count stands at 7 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 7 October 2026 came the latest disclosure, a transaction for €109k in Arbutus Biopharma Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.